← Search

Data · dataset · 2025

Adalimumab-atto

Listed in Virginia Open Data Portal

AMJEVITA (adalimumab-atto) is a biosimilar medication to Humira, containing the active ingredient adalimumab, a monoclonal antibody that blocks tumor necrosis factor (TNF) to reduce inflammation.

Description

It's administered via subcutaneous injection in strengths like 20 mg/0.4 mL and 40 mg/0.8 mL, used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Manufactured by Amgen Inc., it's a prescription drug approved under BLA761024.

This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Adalimumab-atto — *HealthData.Gov* - Adalimumab-aqvh — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

From keywords
Medicine & Health
Inferred from text
Cancer 65% · Disease 75%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portale9d390fd-88ea-44ac-8d73-e307fa97a7f24 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[disease].local:disease:cancerenrichment · data virginia govkeyword-concept-rules@1.0.0title+description (65%)
concepts[disease].local:disease:diseaseenrichment · data virginia govkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0